Your browser doesn't support javascript.
loading
Bacterial ghosts as adjuvant to oxaliplatin chemotherapy in colorectal carcinomatosis.
Groza, Diana; Gehrig, Sebastian; Kudela, Pavol; Holcmann, Martin; Pirker, Christine; Dinhof, Carina; Schueffl, Hemma H; Sramko, Marek; Hoebart, Julia; Alioglu, Fatih; Grusch, Michael; Ogris, Manfred; Lubitz, Werner; Keppler, Bernhard K; Pashkunova-Martic, Irena; Kowol, Christian R; Sibilia, Maria; Berger, Walter; Heffeter, Petra.
Afiliação
  • Groza D; Institute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Gehrig S; Research Cluster "Translational Cancer Therapy Research", University of Vienna and Medical University of Vienna, Austria.
  • Kudela P; Laboratory of MacroMolecular Cancer Therapeutics ( MMCT), Center of Pharmaceutical Sciences, Department of Pharmaceutical Chemistry, University of Vienna, Vienna, Austria.
  • Holcmann M; BIRD-C GmbH & CoKG, Vienna, Austria.
  • Pirker C; Institute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Dinhof C; Institute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Schueffl HH; Institute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Sramko M; Institute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Hoebart J; Research Cluster "Translational Cancer Therapy Research", University of Vienna and Medical University of Vienna, Austria.
  • Alioglu F; BIRD-C GmbH & CoKG, Vienna, Austria.
  • Grusch M; Laboratory of MacroMolecular Cancer Therapeutics ( MMCT), Center of Pharmaceutical Sciences, Department of Pharmaceutical Chemistry, University of Vienna, Vienna, Austria.
  • Ogris M; Laboratory of MacroMolecular Cancer Therapeutics ( MMCT), Center of Pharmaceutical Sciences, Department of Pharmaceutical Chemistry, University of Vienna, Vienna, Austria.
  • Lubitz W; Institute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Keppler BK; Laboratory of MacroMolecular Cancer Therapeutics ( MMCT), Center of Pharmaceutical Sciences, Department of Pharmaceutical Chemistry, University of Vienna, Vienna, Austria.
  • Pashkunova-Martic I; BIRD-C GmbH & CoKG, Vienna, Austria.
  • Kowol CR; Institute of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria.
  • Sibilia M; Research Cluster "Translational Cancer Therapy Research", University of Vienna and Medical University of Vienna, Austria.
  • Berger W; Institute of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria.
  • Heffeter P; Institute of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria.
Oncoimmunology ; 7(5): e1424676, 2018.
Article em En | MEDLINE | ID: mdl-29721389
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Oncoimmunology Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Áustria
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Oncoimmunology Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Áustria